TBX2 and non-small cell lung carcinoma: Nonetheless, given the pragmatic application of DNA methylation profiles as non-invasive biomarkers [16], our observations on the prevalence of TBX2 subfamily hypermethylation in NSCLC suggest that methylation of these genes may serve as a high-potential biomarker for early detection and/or diagnosis of lung cancer.